Traditional Chinese medicine compound preparation for treating cerebral infarction as well as preparation method and application of traditional Chinese medicine compound preparation

The invention discloses a traditional Chinese medicine compound preparation for treating cerebral infarction. The traditional Chinese medicine compound preparation is prepared from the following raw materials in parts by weight: 6-30 parts of ginseng, 3-18 parts of notoginseng powder, 6-45 parts of rhizoma acori graminei, 3-12 parts of leech, 9-90 parts of motherwort, 6-45 parts of arisaema cum bile and 3-30 parts of prepared rhubarb. The invention further discloses a preparation method of the traditional Chinese medicine compound preparation. The traditional Chinese medicine compound preparation disclosed by the invention is capable of improving neuronal behaviors of rats with focal cerebral infarction and pathological structures of cerebral ischemia tissues, reducing cerebral coefficient, the moisture content in brain tissues and cerebral vascular permeability and relieving encephaledema. In addition, the traditional Chinese medicine preparation disclosed by the invention is capable of significantly regulating vascular endothelial growth factor (VEGF) protein of brain tissues of the rats with focal cerebral infarction and expression of mRNA (messenger ribonucleic acid) upwards, and prompting that a close relation is formed between the action mechanism of the traditional Chinese medicine preparation for treating cerebral infarction and promotion of vascular repairing and neogenesis of cerebral infarction ischemia tissues.